| 英語名 | 研究コード | 研究開発ステージ | 会社 | 適応症 | 臨床試験 |
|---|---|---|---|---|---|
| SHR-A1912 | SHR-A1912 | Phase 3 Clinical | Shanghai Hengrui Pharmaceutical Co Ltd | Lymphoma; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse | 詳細 |
| CD19/79b Bi-specific CAR-T Cell Therapy (Shenzhen Geno-Immune Medical Institute) | bi-4SCAR CD19/79b | Phase 2 Clinical | Shenzhen Geno-Immune Medical Institute | Leukemia, B-Cell; Lymphoma, B-Cell | 詳細 |
| TolDCB29 | Phase 2 Clinical | Umc Utrecht | Arthritis, Rheumatoid | 詳細 | |
| JNJ-95566692 | JNJ-95566692 | Phase 1 Clinical | Janssen Research & Development Llc | Lymphoma, Non-Hodgkin | 詳細 |
| LTZ-301 | LTZ-301 | Phase 1 Clinical | LTZ Therapeutics Inc | Autoimmune Diseases; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Mantle-Cell; Lymphoma, Non-Hodgkin | 詳細 |
| CD79b-19 CAR T Cells Therapy (Massachusetts General Hospital) | Phase 1 Clinical | Massachusetts General Hospital | Lymphoma, B-Cell; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Mantle-Cell; Lymphoma, Non-Hodgkin; Primary mediastinal B cell lymphoma | 詳細 | |
| Autologous CD79b-targeting Chimeric Antigen Receptor T-cell Therapy(MD Anderson Cancer Center) | JV-213 | Phase 1 Clinical | The University Of Texas MD Anderson Cancer Center | Lymphoma; Lymphoma, B-Cell | 詳細 |
| NBT-508 | Phase 1 Clinical | Newbio Therapeutics Inc | Lymphoma, B-Cell; Lymphoma, Non-Hodgkin | 詳細 | |
| CD79b CAR-T cell therapy (Yake Biotechnology) | Phase 1 Clinical | Shanghai YaKe Biotechnology Co Ltd, Zhejiang University | Leukemia, Biphenotypic, Acute; Lymphoma, Non-Hodgkin; Precursor Cell Lymphoblastic Leukemia-Lymphoma | 詳細 |
| 英語名 | 研究コード | 研究開発ステージ | 会社 | オリジナル製品名 | 最初に承認をした国 | 最初の適応症 | 最初に承認を受けた会社 | 承認された日付 | 適応症 | 臨床試験 |
|---|---|---|---|---|---|---|---|---|---|---|
| Polatuzumab vedotin | RO-5541077-000; FCU-2711; DCDS-4501A; RG-7596; RO-5541077 | Approved | Genentech Inc, Seagen Inc | Polivy, 优罗华 | United States | Lymphoma, Large B-Cell, Diffuse | Genentech Inc | 2019-06-10 | Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma; Lymphoma, B-Cell; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin | 詳細 |